Industry Background:
Inhalation Anesthesia is used for the induction and maintenance of general anesthesia in the operating room. Anesthesia is a chemical compound with the anesthetic properties and is safe for longer surgical procedures. In the inhalation anesthesia technique, the anesthesia is passed through lungs induces unconsciousness during surgery. Inhalational anesthesia used for sedation, induction, and maintenance of general anesthesia. The rising number of orthopedic procedures and emergency cases has boosted the growth of global inhalation anesthesia market
According to AMA Research, the market for Inhalation Anesthesia is expected to register a CAGR of 4.13% during the forecast period to 2027. This growth is primarily driven by Growing Demand for Surgical Procedures
.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Forecast Period | 2022-2027 |
Volume Unit | N |
Value Unit | USD (Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
The Managed Health Care sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Merck KGaA (Germany), Halocarbon Products Corporation (United States), Hikima Pharmaceuticals PLC (London), Lunan Pharmaceutical Group Co. Ltd. (China), Piramal Enterprises Limited (India), Jiangsu Hengrui Medicine Co. Ltd. (China), Fresenius Kabi AG (Germany), AbbVie Inc. (United States), Baxter International Inc. (United States), Novartis AG (Switzerland) and Troikaa Pharmaceuticals Ltd (India), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
In 2021, International pharmaceutical business, Hikma Pharmaceuticals PLC (Hikma), through its US subsidiary, Hikma Pharmaceuticals USA Inc., has launched Succinylcholine Chloride Injection USP 20mg/mL in the United States. In addition to general anesthesia, it is used for tracheal intubation and to aid in tracheal intubation. Provide skeletal muscle relaxation during surgery or mechanical ventilation.
In 2020, Piramal Critical Care (PCC) has announced a strategic agreement with Medivant Healthcare, a US-based pharmaceutical outsourcing facility, to help address a severe injectable drug shortage in hospitals across the country. and In May 2020, Hikma Pharmaceuticals PLC as a response to COVID-19 shortage has launched Propofol Injectable Emulsion, USP to provide sedative for patients on ventilators in US. The product was made available as 20 mL, 50 mL and 100 mL Vials, in the United States. The product was launched after the approval of its supplemental Abbreviated New Drug Application by the U.S. Food and Drug Administration (FDA).
Inhalation Anesthesia Market Dynamics:
Attributes | Details |
---|
Growth Drivers | - Growing Demand for Surgical Procedures
- Aging Population Suffering Various Chronic Diseases
- Rise in Healthcare Reforms
|
Influencing Trends | - Adoption of Short Duration and Predictable Nature of Inhalation Anesthesia
|
Restraints | - Availability of Generic Products
|
Road Blocks / Challenges | - Side Effects Associated With Anesthetics
|
Gaps & Opportunities | - Increasing Number of Emergency Cases and Accidents
- Rapidly Growing Number of Hospitals in Emerging Countries
- Developing R&D Sector
|
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Data Sources of Inhalation Anesthesia Market Study
Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Inhalation Anesthesia Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.
The primary interviews and data collected as per the below protocols:
By Designation: C-Level, D-Level, Others
By Company Type: Tier 1, Tier 2, Tier 3
Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Inhalation Anesthesia players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.
Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Inhalation Anesthesia Study Sheds Light on
The Inhalation Anesthesia Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Inhalation Anesthesia industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Inhalation Anesthesia industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.